We are making science’s hardest obstacles our highest priority. Rallybio is a clinical-stage biotechnology company built around a team of seasoned industry leaders. Frustrated by the fact that so many devastating diseases still lack adequate treatments, we’ve made it our mission to discover, develop and deliver therapies that meaningfully improve the lives of patients. Our success depends on rallying the best people, partners, and science. It hinges on fearlessly creating paths forward as we strive to develop and deliver the truly transformational. We follow the science wherever it goes. Developing and delivering transformative therapies starts with access to high-quality product candidates. At Rallybio, we believe we have two unique advantages. First, our decades of experience in drug discovery, research, development, regulatory strategy, and manufacturing help us more effectively source, identify, and evaluate therapeutic targets and product candidates with a high probability of success. At the same time, we have an extensive network of relationships with leaders in industry and in academic clinical centers worldwide who know just what we’re looking for—and what we are capable of achieving. Headquartered in New Haven, Connecticut, with an additional location at the University of Connecticut’s Technology Incubation Program in Farmington, Connecticut, Rallybio continues to place considerable scientific resources behind the development of promising product candidates to deliver on its mission. Read our Community Guidelines here: https://bit.ly/3cIcwAx